The angiopep-2 peptide was chosen as the receptor for this system in combination with the dye-brush polymer-coated DCNPs because it could bind with overexpressed low-density lipoprotein receptor-related protein (LRP) on glioma cells. The gene discussed is LRP1; the disease is glioma.